Earn CME: https://www.naccme.com/program/19-aibd-105
In this webcast from the ‘Making the Switch: The Use of Biosimilars in IBD Management’ symposium, held during the 2019 Advances in Inflammatory Bowel Diseases in Orlando, FL, Dr. Alan C. Moss discusses the current landscape of biosimilars available for the treatment of inflammatory bowel disease (IBD).
© 2019 Imedex, an HMP Company
Title: The Current Landscape of Biosimilars in IBD
Sourced From: www.youtube.com/watch?v=hK-EeKn0m6M